Evidence map›Paper›PMID 37285214›Full record

ArticleAdvanced materials (Deerfield Beach, Fla.)2023

Renally Clearable Ultraminiature Chain-Like Gold Nanoparticle Clusters for Multimodal Molecular Imaging of Choroidal Neovascularization.

Van Phuc Nguyen, Wei Qian, Josh Zhe, Jessica Henry, Mingyang Wang, Bing Liu, Wei Zhang, Xueding Wang, Yannis M Paulus

Abstract read
In one paragraph

Article in Advanced materials (Deerfield Beach, Fla.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Long-Term Diabetic Retinopathy Treatment Using Silicon Nanoneedles.Small (Weinheim an der Bergstrasse, Germany) · 2025
    Article
  12. Review
  13. Review
  14. Gold Nanoparticles for Retinal Molecular Optical Imaging.International journal of molecular sciences · 2024
    Review
  15. Review
  16. Article
  17. Article
  18. Molecular and cellular imaging of the eye.Biomedical optics express · 2024
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Van Phuc NguyenDepartment of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, 48105, USA.ORCID https://orcid.org/0000-0001-7466-1483
Wei QianIMRA America, Inc., 1044 Woodridge Ave., Ann Arbor, 48105, MI, USA.
Josh ZheDepartment of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, 48105, USA.
Jessica HenryDepartment of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, 48105, USA.
Mingyang WangDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, 48105, MI, USA.
Bing LiuIMRA America, Inc., 1044 Woodridge Ave., Ann Arbor, 48105, MI, USA.
Wei ZhangDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, 48105, MI, USA.
Xueding WangDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, 48105, MI, USA.
Yannis M PaulusDepartment of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, 48105, USA.

Funding

VIVARIUM MODULEP30EY007003 · NEI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI David Antonetti · 1987 to 2026
$17.6M
Development of Nanoneedle Array for Painless and Long-Term Sustained Intraocular Drug DeliveryR01EY033000 · NEI · PURDUE UNIVERSITY · PI LEE, CHI HWAN, PAULUS, YANNIS MANTAS · 2021 to 2025
$1.9M
Real-time In Vivo Visualization of the Molecular Processes in Choroidal NeovascularizationK08EY027458 · NEI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PAULUS, YANNIS MANTAS · 2018 to 2021
$898k
Novel Nanosecond Laser and Ultrasound to Selectively Treat Eye Blood VesselsR41EY031219 · NEI · PHOTOSONOX LLC · PI PAULUS, YANNIS MANTAS · 2020 to 2020
$225k
NEI NIH HHS 1K08EY027458NEI NIH HHS 1R01EY033000NEI NIH HHS 1R41EY031219NEI NIH HHS K08 EY027458NEI NIH HHS P30 EY007003NEI NIH HHS P30EY007003NEI NIH HHS R01 EY033000NEI NIH HHS R41 EY031219
6 · The paper itself

Abstract

Currently, available gold nanoparticles (GNPs) typically accumulate in the liver and spleen, leading to concerns for their long-term biosafety. To address this long-standing problem, ultraminiature chain-like gold nanoparticle clusters (GNCs) are developed. Via self-assembly of 7-8 nm GNP monomers, GNCs provide redshifted optical absorption and scattering contrast in the near-infrared window. After disassembly, GNCs turn back to GNPs with a size smaller than the renal glomerular filtration size cutoff, allowing their excretion via urine. A one-month longitudinal study in a rabbit eye model demonstrates that GNCs facilitate multimodal molecular imaging of choroidal neovascularization (CNV) in vivo, non-invasively, with excellent sensitivity and spatial resolution. GNCs targeting α

Indexed as

Choroidal NeovascularizationMetal NanoparticlesAnimalsGoldLongitudinal StudiesMolecular ImagingRabbitsTomography, Optical CoherenceGoldage-related macular degenerationcontrast agentsmultimodality molecular ocular imagingoptical coherence tomographyphotoacoustic microscopyrenally clearable ultraminiature chain-like gold nanoparticlesretinal diseases

Identifiers

PMID37285214
PMCPMC10509731

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.